Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 99

1.

Systemic Actions of Breast Cancer Facilitate Functional Limitations.

Wang R, Nakshatri H.

Cancers (Basel). 2020 Jan 13;12(1). pii: E194. doi: 10.3390/cancers12010194. Review.

2.

Interferon-γ signaling is associated with BRCA1 loss-of-function mutations in high grade serous ovarian cancer.

Cardenas H, Jiang G, Thomes Pepin J, Parker JB, Condello S, Nephew KP, Nakshatri H, Chakravarti D, Liu Y, Matei D.

NPJ Precis Oncol. 2019 Dec 6;3:32. doi: 10.1038/s41698-019-0103-4. eCollection 2019.

3.

Cell competition and tumor heterogeneity.

Parker TM, Henriques V, Beltran A, Nakshatri H, Gogna R.

Semin Cancer Biol. 2019 Sep 9. pii: S1044-579X(18)30173-1. doi: 10.1016/j.semcancer.2019.09.003. [Epub ahead of print] Review.

PMID:
31513848
4.

Flower isoforms promote competitive growth in cancer.

Madan E, Pelham CJ, Nagane M, Parker TM, Canas-Marques R, Fazio K, Shaik K, Yuan Y, Henriques V, Galzerano A, Yamashita T, Pinto MAF, Palma AM, Camacho D, Vieira A, Soldini D, Nakshatri H, Post SR, Rhiner C, Yamashita H, Accardi D, Hansen LA, Carvalho C, Beltran AL, Kuppusamy P, Gogna R, Moreno E.

Nature. 2019 Aug;572(7768):260-264. doi: 10.1038/s41586-019-1429-3. Epub 2019 Jul 24.

PMID:
31341286
5.

Death effector domain-containing protein induces vulnerability to cell cycle inhibition in triple-negative breast cancer.

Ni Y, Schmidt KR, Werner BA, Koenig JK, Guldner IH, Schnepp PM, Tan X, Jiang L, Host M, Sun L, Howe EN, Wu J, Littlepage LE, Nakshatri H, Zhang S.

Nat Commun. 2019 Jun 28;10(1):2860. doi: 10.1038/s41467-019-10743-7.

6.

Dual TGFβ/BMP Pathway Inhibition Enables Expansion and Characterization of Multiple Epithelial Cell Types of the Normal and Cancerous Breast.

Prasad M, Kumar B, Bhat-Nakshatri P, Anjanappa M, Sandusky G, Miller KD, Storniolo AM, Nakshatri H.

Mol Cancer Res. 2019 Jul;17(7):1556-1570. doi: 10.1158/1541-7786.MCR-19-0165. Epub 2019 Apr 16.

PMID:
30992305
7.

Genetic Ancestry-dependent Differences in Breast Cancer-induced Field Defects in the Tumor-adjacent Normal Breast.

Nakshatri H, Kumar B, Burney HN, Cox ML, Jacobsen M, Sandusky GE, D'Souza-Schorey C, Storniolo AMV.

Clin Cancer Res. 2019 May 1;25(9):2848-2859. doi: 10.1158/1078-0432.CCR-18-3427. Epub 2019 Feb 4.

PMID:
30718355
8.

MMB triazole analogs are potent NF-κB inhibitors and anti-cancer agents against both hematological and solid tumor cells.

Janganati V, Ponder J, Balasubramaniam M, Bhat-Nakshatri P, Bar EE, Nakshatri H, Jordan CT, Crooks PA.

Eur J Med Chem. 2018 Sep 5;157:562-581. doi: 10.1016/j.ejmech.2018.08.010. Epub 2018 Aug 10.

9.

Effects of a checkpoint kinase inhibitor, AZD7762, on tumor suppression and bone remodeling.

Wang L, Wang Y, Chen A, Jalali A, Liu S, Guo Y, Na S, Nakshatri H, Li BY, Yokota H.

Int J Oncol. 2018 Sep;53(3):1001-1012. doi: 10.3892/ijo.2018.4481. Epub 2018 Jul 13.

10.

Normal Breast-Derived Epithelial Cells with Luminal and Intrinsic Subtype-Enriched Gene Expression Document Interindividual Differences in Their Differentiation Cascade.

Kumar B, Prasad M, Bhat-Nakshatri P, Anjanappa M, Kalra M, Marino N, Storniolo AM, Rao X, Liu S, Wan J, Liu Y, Nakshatri H.

Cancer Res. 2018 Sep 1;78(17):5107-5123. doi: 10.1158/0008-5472.CAN-18-0509. Epub 2018 Jul 11.

11.

Osteocyte-Driven Downregulation of Snail Restrains Effects of Drd2 Inhibitors on Mammary Tumor Cells.

Liu S, Fan Y, Chen A, Jalali A, Minami K, Ogawa K, Nakshatri H, Li BY, Yokota H.

Cancer Res. 2018 Jul 15;78(14):3865-3876. doi: 10.1158/0008-5472.CAN-18-0056. Epub 2018 May 16.

12.

Dependence receptor UNC5A restricts luminal to basal breast cancer plasticity and metastasis.

Padua MB, Bhat-Nakshatri P, Anjanappa M, Prasad MS, Hao Y, Rao X, Liu S, Wan J, Liu Y, McElyea K, Jacobsen M, Sandusky G, Althouse S, Perkins S, Nakshatri H.

Breast Cancer Res. 2018 May 2;20(1):35. doi: 10.1186/s13058-018-0963-5.

13.

Attraction and Compaction of Migratory Breast Cancer Cells by Bone Matrix Proteins through Tumor-Osteocyte Interactions.

Chen A, Wang L, Liu S, Wang Y, Liu Y, Wang M, Nakshatri H, Li BY, Yokota H.

Sci Rep. 2018 Apr 3;8(1):5420. doi: 10.1038/s41598-018-23833-1.

14.

An Effective Epigenetic-PARP Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA Mutations.

Pulliam N, Fang F, Ozes AR, Tang J, Adewuyi A, Keer H, Lyons J, Baylin SB, Matei D, Nakshatri H, Rassool FV, Miller KD, Nephew KP.

Clin Cancer Res. 2018 Jul 1;24(13):3163-3175. doi: 10.1158/1078-0432.CCR-18-0204. Epub 2018 Apr 3.

15.

Inhibiting checkpoint kinase 1 protects bone from bone resorption by mammary tumor in a mouse model.

Liu S, Liu Y, Minami K, Chen A, Wan Q, Yin Y, Gan L, Xu A, Matsuura N, Koizumi M, Liu Y, Na S, Li J, Nakshatri H, Li BY, Yokota H.

Oncotarget. 2018 Jan 19;9(10):9364-9378. doi: 10.18632/oncotarget.24286. eCollection 2018 Feb 6.

16.

A Spectrum Graph-Based Protein Sequence Filtering Algorithm for Proteoform Identification by Top-Down Mass Spectrometry.

Yang R, Zhu D, Kou Q, Bhat-Nakshatri P, Nakshatri H, Wu S, Liu X.

Proceedings (IEEE Int Conf Bioinformatics Biomed). 2017 Nov;2017:222-229. doi: 10.1109/BIBM.2017.8217653. Epub 2017 Dec 18.

17.

Inflammation-associated microRNA changes in circulating exosomes of heart failure patients.

Beg F, Wang R, Saeed Z, Devaraj S, Masoor K, Nakshatri H.

BMC Res Notes. 2017 Dec 19;10(1):751. doi: 10.1186/s13104-017-3090-y.

18.

Mutational landscape of RNA-binding proteins in human cancers.

Neelamraju Y, Gonzalez-Perez A, Bhat-Nakshatri P, Nakshatri H, Janga SC.

RNA Biol. 2018 Jan 2;15(1):115-129. doi: 10.1080/15476286.2017.1391436. Epub 2017 Nov 14.

19.

Pharmacological Dual Inhibition of Tumor and Tumor-Induced Functional Limitations in a Transgenic Model of Breast Cancer.

Wang R, Bhat-Nakshatri P, Padua MB, Prasad MS, Anjanappa M, Jacobson M, Finnearty C, Sefcsik V, McElyea K, Redmond R, Sandusky G, Penthala N, Crooks PA, Liu J, Zimmers T, Nakshatri H.

Mol Cancer Ther. 2017 Dec;16(12):2747-2758. doi: 10.1158/1535-7163.MCT-17-0717. Epub 2017 Oct 4.

20.

Reduction in Migratory Phenotype in a Metastasized Breast Cancer Cell Line via Downregulation of S100A4 and GRM3.

Chen A, Wang L, Li BY, Sherman J, Ryu JE, Hamamura K, Liu Y, Nakshatri H, Yokota H.

Sci Rep. 2017 Jun 14;7(1):3459. doi: 10.1038/s41598-017-03811-9.

Supplemental Content

Loading ...
Support Center